Cardiovascular risk assessment: a comparison of the Framingham, PROCAM, and DAD equations in HIV-infected persons.
about
Metabolic syndrome, diabetes, and cardiovascular risk in HIVCardiovascular risk prediction in HIV-infected patients: comparing the Framingham, atherosclerotic cardiovascular disease risk score (ASCVD), Systematic Coronary Risk Evaluation for the Netherlands (SCORE-NL) and Data Collection on Adverse Events ofSmoking and projected cardiovascular risk in an HIV-positive Asian regional cohort.Incidence of Diabetes Mellitus and Obesity and the Overlap of Comorbidities in HIV+ Hispanics Initiating Antiretroviral Therapy.Cardiovascular disease risk prediction by the American College of Cardiology (ACC)/American Heart Association (AHA) Atherosclerotic Cardiovascular Disease (ASCVD) risk score among HIV-infected patients in sub-Saharan AfricaAssessment of cardiovascular risk factors in people with HIV infection treated with ART in rural South Africa: a cross sectional studyThe association between alcohol use and cardiovascular disease among people living with HIV: a systematic review.Management of lipid disorders in patients living with HIV.Ideal Cardiovascular Health and Carotid Atherosclerosis in a Mixed Cohort of HIV-Infected and Uninfected Ugandans.Coronary Artery Disease in HIV-Infected Patients: Downside of Living Longer.The Boehringer Ingelheim employee study (Part 2): 10-year cardiovascular diseases risk estimation.Assessment of the agreement between the Framingham and DAD risk equations for estimating cardiovascular risk in adult Africans living with HIV infection: a cross-sectional study.Relationship between estimated cardiovascular disease risk and insulin resistance in a black African population living with HIV: a cross-sectional study from Cameroon.CHA2DS2-VASc Score, Warfarin Use, and Risk for Thromboembolic Events Among HIV-Infected Persons With Atrial Fibrillation.Serum lipid and glucose profiles in HIV-positive Nigerian children.Cardiovascular Disease in the Setting of Human Immunodeficiency Virus Infection.International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK
P2860
Q26853470-AE7D3697-E6B8-45E7-A1DD-4C0419ECA741Q30987054-5A3A1DA1-C6F4-47B5-8C5B-5D19539CB4FEQ36080709-24D4AA94-884F-45FF-BFD7-1C611FD88A1FQ36100031-A57DCD04-78CF-4070-850B-7E7D7258EBB5Q36290172-711756B9-5563-4FEE-8C9C-8944097B472AQ36364201-C2D10905-99E9-4A22-8A34-0AAB948A4303Q36389888-FCE387B9-181D-427B-92FA-B8C31C4A0234Q38344129-7CBE56D7-A282-47EB-99A8-1E3BE16B90CCQ38853601-9DD4A0A7-18EF-4DEB-8796-DCE201617C7DQ39165028-2398E465-5AC2-4B27-A860-9E3B8000728CQ39624244-174BF41F-02E9-44A7-A811-459A76F68654Q40051912-10F8B1B2-2F5C-406E-AC0E-8CA0B1489286Q40085569-BE7C3E43-245E-4378-A064-522D47BFF1B9Q40098541-8A23FF93-4BFB-42BF-9EF0-E4B1DEC83F81Q42334793-BBCC5714-833F-4917-90E9-59B775AD7FB9Q51779710-160C725C-2526-4436-B0BD-086CE58BB0BCQ56762706-C7B9337C-2452-488C-B4FD-E403FD58D517
P2860
Cardiovascular risk assessment: a comparison of the Framingham, PROCAM, and DAD equations in HIV-infected persons.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Cardiovascular risk assessment ...... tions in HIV-infected persons.
@en
Cardiovascular risk assessment ...... tions in HIV-infected persons.
@nl
type
label
Cardiovascular risk assessment ...... tions in HIV-infected persons.
@en
Cardiovascular risk assessment ...... tions in HIV-infected persons.
@nl
prefLabel
Cardiovascular risk assessment ...... tions in HIV-infected persons.
@en
Cardiovascular risk assessment ...... tions in HIV-infected persons.
@nl
P2093
P2860
P356
P1476
Cardiovascular risk assessment ...... tions in HIV-infected persons.
@en
P2093
Aline de Cássia Oliveira de Castro
Clarissa Alencar de Sousa
Jorge Tannus Esper
Luis Carlos Silva e Souza
Marianne de Oliveira Falco
Marília Dalva Turchi
Max Weyler Nery
P2860
P304
P356
10.1155/2013/969281
P407
P577
2013-10-21T00:00:00Z